These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7987782)

  • 1. [Positive and negative symptoms in schizophrenia: a current overview].
    Roy MA; DeVriendt X
    Can J Psychiatry; 1994 Sep; 39(7):407-14. PubMed ID: 7987782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of primary negative symptoms in schizophrenia: an one-year observational study.
    Franza F; Fasano V; De Guglielmo S; Solomita B
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S245-9. PubMed ID: 26417773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative symptoms of schizophrenia: a problem that will not go away.
    Stahl SM; Buckley PF
    Acta Psychiatr Scand; 2007 Jan; 115(1):4-11. PubMed ID: 17201860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary and secondary negative symptoms: a useful differentiation? An empirical study].
    Barnett W; Mundt C; Richter P
    Nervenarzt; 1996 Jul; 67(7):558-63. PubMed ID: 8927194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of negative symptoms in schizophrenia.
    Möller HJ
    Eur Psychiatry; 2007 Sep; 22(6):380-6. PubMed ID: 17524626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two factors of experienced deficits in schizophrenia and their relationships with positive, negative, and depressive symptoms.
    Iwawaki A; Narushima K; Ota K; Okura T; Tsuchiya K; Takashima A
    Compr Psychiatry; 1998; 39(6):386-91. PubMed ID: 9829147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive inhibition and schizophrenic symptom subgroups.
    Williams LM
    Schizophr Bull; 1996; 22(1):139-51. PubMed ID: 8685656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
    Schooler NR
    Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model.
    Lenzenweger MF; Dworkin RH; Wethington E
    Schizophr Bull; 1991; 17(3):515-24. PubMed ID: 1947875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of primary negative symptoms in schizophrenic and other psychiatric patients].
    Gerbaldo H; Müller-Siecheneder F
    Fortschr Neurol Psychiatr; 1996 Jun; 64(6):221-7. PubMed ID: 8766995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative priming (cognitive inhibition) in psychiatric patients: effect of neuroleptics.
    David AS
    J Nerv Ment Dis; 1995 May; 183(5):337-9. PubMed ID: 7745390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.